The rise of Sildenafil initially fueled a surge for the drug industry, nevertheless recent developments present a murky scenario for shareholders. Generic versions are eroding earnings, and continued patent challenges https://murraykmsu000741.blogpixi.com/41525104/sildenafil-and-pharma-a-precarious-bet